ArticlePloS one2025

Neutralizing monoclonal antibodies improve biodistribution of intravenously administered oncolytic adenovirus in human CD46-transgenic mice.

Masahisa Hemmi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.